FDA NDC Directory · JSON-LD · Markdown

Rifabutin

NDC 10135-738 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerMarlex Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA215041
Dosage form / routeCAPSULE · ORAL
Active ingredientsRIFABUTIN (150 mg/1)
Marketing started20220501
Package count1

External sources

Source: openFDA. Public-domain (CC0).